Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis

NCT00556075 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

67

Enrollment

INDUSTRY

Sponsor class

Stopped Clinical hold for safety

Conditions

Endometriosis

Interventions

DRUG: Proellex 25 mg
DRUG: Placebo
DRUG: Proellex 50 mg

Sponsor

Repros Therapeutics Inc.